Anaplastic thy roid can cer (ATC) is one of the most ag gres sive tu mors in hu man med i cine. Despite the multimodal ther apy, the av er age survival of pa tients is just sev eral months. For tunately, it is an ex tremely rare tu mor. Most fre quently, ATC oc curs in the el derly, with the av er age age of the pa tients be ing al most 70 years. It is ex tremely rare that ATC oc curs in peo ple un der the age of 40. We re port a case of a 33 year old woman with ATC, with the di am e ter of the tu mor being 8x7cm, con firmed by histopathology and imunohis to chem is try. In Jan u ary 2001, a to tal thyroidectomy was per formed, and the tu mor was com pletely resected. Post op er a tively, the pa tient re ceived ra di ation ther apy. Ten years af ter the sur gery, on reg u lar check-ups, the pa tient is still liv ing and there is no ev idence of a re cur rent tu mor or metastases. This case is in struc tive for two rea sons, as it shows that ATC can oc cur in youn ger peo ple and that there is a pos si bil ity of long term sur vival.
A naplastic thy roid can cer (ATC) is one of the most ag gres sive tu mors in hu man med i cine. The av er age sur vival is usu ally ex pressed in weeks or months, de spite the multimodal ther apy which con sid ers sur gi cal treatment and ra dio ther apy, while che mo ther apy is rarely used. For tu nately, ATC is a rare tu mor with an in ci dence rate of 2/1,000,000. In struc ture of all ma lig nant tu mors, ATC takes part in 1-2%, but it is re spon si ble for al most half of all deaths due to thy roid car ci noma. ATC most fre quently oc curs in the sev enth de cade, and it is extremely rare in peo ple un der age of 40. 1,2. We are pre sent ing the case of our youn gest pa tient diag nosed with ATC, and, on the other hand, the pa tient with the lon gest sur vival in our in sti tu tion, and one of the rare cases pub lished in lit er a ture with 10 year sur vival.
CASE RE PORT:
A 33 year old woman was ad mit ted to the hos pi tal for a sched uled sur gery in our in sti tu tion, in Jan u ary 2001. One month prior to the hos pi tal ad mis sion, the pa tient no ticed non-pain ful, fast grow ing ten der ness on the right side of the neck. The ul tra sound of the neck re vealed a sol i tary hypoehogenic nod ule in the right thy roid lobe, with a di am e ter of 4x3cm. The rest of the thy roid tis sue was ho mog e nous. No en larged lymph nodes were de tectable in the neck by the ul tra sound. The scintigraphy revealed a non func tional node. The pa tient was euthyroid, and the anti-thyreoglobuline and antiperoxidase an ti bodies were neg a tive. The value of se rum cal cium was within the ref er ence range. A fine nee dle as pi ra tion biopsy re vealed a ma lig nant tu mor.
At the time of hos pi tal ad mis sion, the pa tient did not have any pain. Phys i cal ex am i na tion showed a non-tender node in right thy roid lobe, with a di am e ter of 7 cm (it dou bled its size in less than a month). The node had an elas tic con sis tency, it was pain less, and less mov able during swal low ing. The phys i cal ex am i na tion did not re veal cer vi cal lympadenoapthy. The laryngoscopy showed that both vo cal cords were sym met ri cally mov able. The chest X-ray pre sented a de vi a tion of the tra chea to the left. Bio chem i cal anal y ses showed only a higher eryth ro cyte sed i men ta tion rate (70 mm/h). The pa tient's his tory was clear from other ma lig nant dis eases, pre vi ous neck ra di ation, other en do crine dis or ders or pre vi ous sur ger ies. The pa tient was free from other chronic ill ness and med i cal treat ment. The fam ily his tory was neg a tive for thy roid dis or ders. She was not an in hab it ant of an en demic goi ter re gion. Intraoperativelly, the tu mor of the right thy roid e m i z e r lobe was iden ti fied, par tially with cap sule pen e tra tion and in fil tra tion of the sub hyoid mus cles. The to tal thyroidectomy en bloc with in fil trated mus cle was performed. No thy roid rem nant was seen mac ro scop i cally. Fig ure 1 . shows a gross sec tion of the tu mor. Re li able iden ti fi ca tion and pres er va tion of parathyroid glands and re cur rent la ryn geal nerve on the left side of the neck was achieved. On the right side of neck, the re cur rent la ryngeal nerve was care fully dis sected from the tu mor. The ex tem pore bi opsy pointed to ATC. The de fin i tive histopathology (HE stain) showed gigantocellar type of ATC, com posed of the gi ant cells, with the nu mer ous atypic nu clei, mi totic fig ures, ex pressed pleomorphism and ar eas of the ne cro sis (Fig ure 2) . This find ing confirms the ex tem pore bi opsy. The immunohistochemistry was used to eval u ate the tu mor. It did not ex press the thy roglob u lin and calcitonin stains, but it was pos i tive for cytokeratin.
The post op er a tive course went well. The phonation was re mark able. The val ues of se rum cal cium were over 2.0 mmol/l. She was dis charged from hos pi tal on the fourth post op er a tive day. The sub sti tu tion with L-thy roxine started im me di ately, first with 100 mcg per day, and af ter a month the dos age was in creased to 125 mcg per day. Six weeks af ter the sur gery, ra dio ther apy was applied (30Gy). Che mo ther apy was not used. For the pos sibil ity that ATC orig i nated from dif fer en ti ated thy roid can cer, six months fol low ing the sur gery the scintigraphy of the neck and whole body scan was per formed. Ex am ina tion was re mark able.
Ten years af ter the sur gery pa tient is still liv ing. She is com ing to the reg u lar six-month check-ups. At these check-ups, the pa tient was phys i cally ex am ined, ul trasound of the neck and ab do men, chest X rays were done. Based upon these re sults, no signs for re cur rence of the dis ease nor me tas ta sis were pres ent. The TG val ues are not mea sur able, and the TSH val ues are rang ing from 0.3 to 0.5 mU/L.
DISCCUSION
We have de cided to re port this case be cause of two reasons:
1. So far, this is our youn gest ATC pa tient, among 150 ATC pa tients di ag nosed in the past 15 years. 1 It be longs to a youn ger group of ATC pa tients in lit er a ture published thus far. More than 90% of pa tients are older than 50 years, while the in ci dence rate un der 40 years of age is ex tremely low. 1, 2 This case il lus trates that, in dif fer ential di ag no sis of thy roid al ter ations in youn ger pa tients, ATC should be kept in mind.
2. On the other hand, this is our pa tient with the lon gest sur vival, and it also shows that sur vival is pos si ble in ATC pa tients, de spite the fact that ATC is a tu mor with one of the worse prog no ses. It is ironic that one of the most in do lent tu mors in hu man med i cine -pap il lary cancer, and also one the most fa tal hu man can cers -ATC can orig i nate from the thy roid gland. Besic et al. 3 , an alyzed 188 ATC pa tients. They found that the me dian survival was 3 months, one-year sur vival 13%, two-year survival 6%. Their study showed that dur ing the first month af ter the es tab lish ment of the di ag no sis, 20% of pa tients died, and dur ing first two months, 33% of ATC pa tients died. Ac cord ing to the re sults of Kihare et al 4 , the av erage sur vival of ATC pa tients was 9 months, one-year survival was 21%, two-year sur vival 11% and five-year survival was 5%. Yau et al. 5 , an a lyzed 50 ATC pa tients, and the re sults showed that the me dian of sur vival was 3 months, one year sur vival 14%, and three-year sur vival was 8%. Me dian of sur vival in ATC pa tients was 4 months, found by Haigh et al. 6 One year sur vival, which ranged from 10-15% of pa tients, was found by Sugitani et al. 7 , and Gilliland et all. 8 . Is it hard to find the ATC patients with five-year sur vival. This fact is op po site to the opin ion of some au thors, that pa tients, with out signs of the dis ease five years af ter the sur gery, are cured. Some au thors think that long term sur vival in ATC pa tients is caus ing the doubt in the ad e quate di ag no sis and that is also nec es sary to re eval u ate the di ag no sis. In this case, we re eval u ated the di ag no sis. The re vi sion of the spec imen and ad di tional immunohistochemisty test were ordered from the pa thol o gist, but these tests also con firmed the di ag no sis of ATC. We can only make the as sump tion that the age of the pa tient had spe cial in flu ence over this long term sur vival, be cause the same model of treat ment was ap plied in other pa tients. Ac cord ing to the lit er a ture, the prog no sis of the ATC pa tients de pends on the age of the pa tient. Lon ger sur vival can be ex pected in youn ger pa tients. Besic et al. 3 claim that ATC pa tients over the age of 70 have a 1.5 times higher risk of shorter sur vival than pa tients un der age of 70. Ac cord ing to a univariate re gres sion anal y sis con ducted in this study, comorbidity is sig nif i cantly statis ti cally cor re lated with sur vival, but it is not an in depend ent fac tor an a lyzed by multivariate re gres sion anal ysis. Yau et al. 5 found that sur vival is sta tis ti cally lon ger in pa tients un der age of 65. The rea son for that might be comorbidity, usu ally found in the older pa tients. Giuffrida et al. 9 and Kebebew et al. 10 , found that sur vival is lon ger in ATC pa tients un der age of 60. Gilliland et al. 8 found that one year sur vival is de creas ing in ATC patients as the age of the pa tient rises. In con trast with other au thors, re sults of Haigha et al. 6 and Sugitani et al. 7 , showed that the age of pa tients did not have any in fluence on sur vival in of the ATC pa tients.
Con clu sions: This case is in struc tive for two rea sons, as it shows that ATC can oc cur in youn ger peo ple and that there is a pos si bil ity of long term sur vival.
SUM MARY
Anaplasti~è ni karcinom štitaste `lezde je jedan od najagresivnijih tumora u humanoj medicini. I pored multimodalne terapije, proseèno pre`ivljavanje obolelih je svega nekoliko meseci. Na sre}u, ovaj tu mor je veoma redak. Naj~è eš}e se javlja kod starijih pacijenata, pri ~è emu je prose~è na starost obolelih 70 godina, a izuzetno retko se javlja kod pacijenata mladjih od 40 godina. Ovde prikazujemo slu~è aj tridesettrogodišnje bolesnice sa anaplastiènim karcinomom, promera 8x7cm, što je potvrdjeno histopatološki i imunohistohemijski. Januara 2001.godine u~injena je totalna tiroidektomija, tu mor je u potpunosti reseciran. Postoperativno bolesnica je podvrgnuta zra~noj terapiji. Deset godina nakon op eracije, bolesnica nema recidiv tumora niti metastaze.
Ovaj slu~è aj je zna~è ajan iz dva razloga, prvo zato što pokazuje da se anaplastièni karcinom mo`e javiti i kod mladjih osoba, a zatim i zato što pokazuje da je kod ovih bolesnika mogu}e dugoroèno pre`ivljavanje.
Klju~ne re~è i: anaplasti~è ni karcinom štitaste `lezde; {titasta `lezda; pre`ivljavanje
